InSpek

Cover Block

Metric	Value
Name	InSpek
Tagline	Raman-on-a-chip photonic sensors for bioprocess monitoring
Headquarters	Paris, France
Founded	2021
Stage	Seed
Business Model	Hardware + Software
Industry	Deeptech
Technology	Hardware
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	Seed (total disclosed ~$7,240,000)

Links

• Website: https://www.inspek-solutions.com/
• LinkedIn: https://www.linkedin.com/company/inspek-solutions/

The Short Version

InSpek is developing a hardware platform to bring laboratory-grade chemical analysis directly into biopharmaceutical manufacturing lines. The Paris-based deeptech startup, founded in 2021, is building "Raman-on-a-chip" sensors, which combine integrated photonics and machine learning to monitor multiple process parameters in real time [CB Insights, Sep 2025]. The core bet is that shrinking Raman spectroscopy onto a photonic integrated circuit will enable continuous, at-line monitoring for single-use bioreactors [inspek-solutions.com].

Founder Jérôme Michon holds a PhD in integrated optics from MIT following studies at École Polytechnique, and the company has assembled a team of 14, including six PhDs in optics, biotech, and AI [École polytechnique, 2026] [PIC Magazine, 2026]. The company is in a capital-intensive development phase, supported by a €3.5 million seed round co-led by Breega and Wind, supplemented by a €2.5 million grant from the European Innovation Council [Quantonation, 2024-09]. Over the next 12-18 months, the critical milestones to watch will be the transition from prototype to validated product and the announcement of initial pilot deployments with biopharma partners.

Data Accuracy: GREEN -- Core company description, funding details, and team background corroborated by multiple independent sources (CB Insights, Quantonation, École polytechnique).

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	Hardware + Software
Industry / Vertical	Deeptech
Technology Type	Hardware
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	Seed (total disclosed ~$7,240,000)

The Company in Brief

InSpek was founded in September 2021 by Jérôme Michon, an optics engineer with a PhD from MIT, to commercialize a new approach to chemical sensing [École polytechnique, 2026]. The company is headquartered in Paris, France, and operates as a hardware-focused deeptech startup targeting the biopharmaceutical industry [Crunchbase]. Its founding premise was to apply integrated photonics to the challenge of real-time, multiparametric monitoring in bioprocesses [CB Insights, Sep 2025].

The company's early development was supported by non-dilutive funding, including the 2022 X-Grant Silicon Valley Prize [École polytechnique, 2026]. A significant milestone was reached in September 2024 with the announcement of a €6 million financing package. This comprised a €3.5 million seed round co-led by Breega and Wind, with participation from Quantonation, complemented by a €2.5 million grant from the European Innovation Council (EIC) Accelerator program [EU-Startups, Sep 2024] [Quantonation, 2024-09]. This capital infusion, which brought total disclosed funding to approximately $7.24 million, is earmarked for advancing hardware development and scaling the team [CB Insights, Sep 2025].

By 2026, the team had grown to 14 full-time staff, including six PhDs specializing in optics, biotechnology, and artificial intelligence [PIC Magazine, 2026]. The company lists a Chief of Staff, Tifenn Naour, among its leadership [LinkedIn, 2026]. Co-founder Ivan-Lazar Bundalo is also identified in investor materials [Quantonation, 2024-09].

Data Accuracy: GREEN -- Founding details, funding amounts, and team size are corroborated by multiple independent sources including EU-Startups, Quantonation, and PIC Magazine.

What They Have Built

InSpek's core proposition is a hardware sensor system that applies the principles of Raman spectroscopy to the industrial scale of bioprocess manufacturing. The technology aims to replace bulky, expensive laboratory instruments with compact, integrated photonic circuits that can be embedded directly into single-use bioreactors [CB Insights, Sep 2025].

The product is described as enabling real-time, multiparametric monitoring of biological and chemical processes [CB Insights]. In practice, this means the sensor could track multiple critical variables, such as glucose, lactate, or antibody titers, simultaneously without requiring manual sampling. The company's website frames this as "enlightening your processes" through "Raman-on-a-chip integrated photonic sensors" [inspek-solutions.com]. AI is cited as a component for spectral analysis and data interpretation [CB Insights].

With six PhDs specialized in optics, biotech, and AI among its 14 full-time staff, the development effort appears heavily weighted toward advancing the photonic integrated circuits (PICs) and the proprietary algorithms needed to make them work in a noisy industrial environment [PIC Magazine, 2026].

Data Accuracy: YELLOW -- Product claims are consistent across multiple sources, but technical specifications and performance data are not publicly available.

Market Size and Demand

The market for advanced bioprocess monitoring is being reshaped by a push for efficiency and regulatory compliance. InSpek's target segment sits at the intersection of biopharmaceutical manufacturing and advanced photonic sensing.

The global market for process analytical technology (PAT), which includes spectroscopy and other inline monitoring tools, was valued at approximately $4.5 billion in 2024 and is projected to grow at a compound annual rate of 13% through 2030 [Grand View Research, 2024]. This growth is driven by the pharmaceutical industry's adoption of Quality by Design (QbD) principles and a regulatory emphasis on real-time release testing.

Key demand drivers include the shift towards single-use bioreactors and continuous bioprocessing, which creates a need for sensors that are easily integrated into sterile, closed systems [Laser Focus World, 2026]. Concurrently, the rise of complex biologic drugs requires monitoring of more subtle metabolic parameters than traditional pH and dissolved oxygen, pushing the limits of existing sensor technology.

Metric	Value
Process Analytical Tech (PAT) Market 2024	$4.5B
Projected CAGR 2024-2030	13%

Data Accuracy: YELLOW -- Market sizing is from an analogous third-party report; specific TAM for Raman-on-a-chip in bioprocess monitoring is not cited.

Who Else Is Fighting for This

InSpek positions itself as a hardware-first challenger to conventional optical sensing systems used in bioprocess monitoring. No named direct competitors were identified in the company's public sources [CB Insights, Sep 2025].

The competitive map segments into three layers:

• Incumbent instrument vendors. Companies like Thermo Fisher Scientific and Horiba supply benchtop Raman spectrometers. Their advantage is entrenched customer relationships; their vulnerability is high cost and lack of integration into continuous bioprocess workflows.
• Emerging software & sensor challengers. A newer wave of companies applies machine learning to process data from various sensor types. InSpek's potential edge is controlling both the novel sensor hardware and the analytics layer.
• Adjacent substitute technologies. Other analytical techniques like Near-Infrared (NIR) spectroscopy or mass spectrometry are used for similar monitoring tasks.

InSpek's most defensible edge today appears to be its specialized talent stack and grant-backed R&D runway. The team composition of 14 full-time staff, including six PhDs specialized in optics, biotech, and AI, represents a concentration of cross-disciplinary expertise rare at the seed stage [PIC Magazine, 2026]. This is compounded by non-dilutive capital from the European Innovation Council Accelerator grant [CB Insights, Sep 2025].

Data Accuracy: YELLOW -- Competitive landscape is inferred from market segments; no direct competitors named in public research.

Sources

1. [CB Insights, Sep 2025] InSpek - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/inspek
2. [inspek-solutions.com] InSpek • Enlightening your processes | https://www.inspek-solutions.com/
3. [EU-Startups, Sep 2024] Paris-based InSpek secures €6 million to accelerate biomanufacturing with photonics | https://www.eu-startups.com/2024/09/paris-based-inspek-secures-e6-million-to-accelerate-biomanufacturing-with-photonics/
4. [Crunchbase] InSpek - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/inspek
5. [LinkedIn, 2026] Tifenn NAOUR - InSpek | LinkedIn | https://www.linkedin.com/in/tifenn-naour-33613119a/
6. [Laser Focus World, 2026] Versatility, continued advancement help Raman spectroscopy shine | Laser Focus World | https://www.laserfocusworld.com/biolife-sciences/article/14279794/versatility-continued-advancement-help-raman-spectroscopy-shine
7. [École polytechnique, 2026] InSpek and invisensing.io start-ups awarded the 2022 “X-Grant Silicon Valley” Prize - École polytechnique | https://www.polytechnique.edu/en/press-room/press-releases/inspek-and-invisensingio-start-ups-awarded-2022-x-grant-silicon-valley-prize-0
8. [PIC Magazine, 2026] InSpek has 14 full-time staff, including 6 PhDs specialised in optics, biotech and AI |
9. [Quantonation, 2024-09] Inspek secures €6M seed funding to accelerate biomanufacturing | https://www.quantonation.com/2024/09/27/inspek-secures-e6m-seed-funding-to-accelerate-biomanufacturing/
10. [Grand View Research, 2024] Process Analytical Technology (PAT) Market Size, Share & Trends Analysis Report |